food companies blocking glp 1 Slideshow: GLP-1 friendly innovations on the upswing Caution advised for GLP-1 labeling
Description
The GLP-1 market is projected to exceed 100B USD by 2030
Nevertheless, the overall drug exposure was not considered clinically significant
The demand for GLP-1 medications is rapidly increasing, with the market expected to reach $13.6 billion globally by 2028 (source: Research and Markets)
Omega-3
Sarcopenia is an age-related syndrome characterized by a progressive and extensive decline in skeletal muscle mass and function, leading to serious impairment of the quality of life and poor health prognosis in older adults
